Citation:Díaz-Rubio E, Gómez-España A, Massutí B, Sastre J, Abad A, Valladares M, et al 2012

From Cancer Guidelines Wiki

Jump to:navigation, search

Citation

Díaz-Rubio E, Gómez-España A, Massutí B, Sastre J, Abad A, Valladares M, et al. First-line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: the phase III MACRO TTD study. Oncologist 2012;17(1):15-25 Available from: http://www.ncbi.nlm.nih.gov/pubmed/22234633.

Critical appraisals

Assign a critical appraisal

Compare quality appraisals for each clinical question

Cited by

Subsequent treatment and the continuum-of-care model

Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Díaz-Rubio_E,_Gómez-España_A,_Massutí_B,_Sastre_J,_Abad_A,_Valladares_M,_et_al_2012&oldid=152657"